What was the market valuation of the US autoimmune disease-diagnostics market in 2024?

The market valuation was $1272.58 Million in 2024. Read More

What is the projected market valuation for the US autoimmune disease-diagnostics market by 2035?

The projected valuation for 2035 is $2602.62 Million. Read More

What is the expected CAGR for the US autoimmune disease-diagnostics market during the forecast period 2025 - 2035?

The expected CAGR is 6.72% during the forecast period 2025 - 2035. Read More

Which test type segment had the highest valuation in 2024?

Molecular Diagnostics had the highest valuation at $400.0 Million in 2024. Read More

What is the projected valuation for the Biopsies segment by 2035?

The projected valuation for the Biopsies segment is $702.62 Million by 2035. Read More

Which disease type segment is expected to show significant growth by 2035?

Thyroid Disorders is expected to show significant growth, with a projected valuation of $802.62 Million by 2035. Read More

What was the valuation of the Diagnostic Laboratories segment in 2024?

The valuation of the Diagnostic Laboratories segment was $600.0 Million in 2024. Read More

Which product type segment is anticipated to have the highest growth by 2035?

Reagents are anticipated to have the highest growth, with a projected valuation of $1200.0 Million by 2035. Read More

Who are the key players in the US autoimmune disease-diagnostics market?

Key players include Abbott Laboratories, Roche Holding AG, and Thermo Fisher Scientific Inc. Read More

What was the valuation of the Multiple Sclerosis segment in 2024?

The valuation of the Multiple Sclerosis segment was $250.0 Million in 2024. Read More

US Autoimmune Disease Diagnostics Market

ID: MRFR/LS/14149-HCR

100 Pages

Satyendra Maurya

Last Updated: April 06, 2026

US Autoimmune Disease Diagnostics Market Research Report: Size, Share, Trend Analysis By Test Type (Serological Tests, Molecular Diagnostics, Imaging Tests, Biopsies), By Disease Type (Rheumatoid Arthritis, Lupus, Multiple Sclerosis, Type 1 Diabetes, Thyroid Disorders), By End Users (Hospitals, Diagnostic Laboratories, Research Institutes) and By Product Type (Reagents, Instrumentations, Software) - Growth Outlook & Industry Forecast 2025 To 2035

US Autoimmune Disease Diagnostics Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Chemicals and Materials, BY Test Type (USD Million)
  1. 4.1.1 Serological Tests
  2. 4.1.2 Molecular Diagnostics
  3. 4.1.3 Imaging Tests
  4. 4.1.4 Biopsies
2. 4.2 Chemicals and Materials, BY Disease Type (USD Million)
  1. 4.2.1 Rheumatoid Arthritis
  2. 4.2.2 Lupus
  3. 4.2.3 Multiple Sclerosis
  4. 4.2.4 Type 1 Diabetes
  5. 4.2.5 Thyroid Disorders
3. 4.3 Chemicals and Materials, BY End-user (USD Million)
  1. 4.3.1 Hospitals
  2. 4.3.2 Diagnostic Laboratories
  3. 4.3.3 Research Institutes
4. 4.4 Chemicals and Materials, BY Product Type (USD Million)
  1. 4.4.1 Reagents
  2. 4.4.2 Instrumentations
  3. 4.4.3 Software
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Abbott Laboratories (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Roche Holding AG (CH)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Thermo Fisher Scientific Inc. (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Siemens Healthineers AG (DE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Bristol-Myers Squibb Company (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Quest Diagnostics Incorporated (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Bio-Rad Laboratories Inc. (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Genzyme Corporation (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TEST TYPE
3. 6.3 US MARKET ANALYSIS BY DISEASE TYPE
4. 6.4 US MARKET ANALYSIS BY END-USER
5. 6.5 US MARKET ANALYSIS BY PRODUCT TYPE
6. 6.6 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF CHEMICALS AND MATERIALS
9. 6.9 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
10. 6.10 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
11. 6.11 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
12. 6.12 CHEMICALS AND MATERIALS, BY TEST TYPE, 2024 (% SHARE)
13. 6.13 CHEMICALS AND MATERIALS, BY TEST TYPE, 2024 TO 2035 (USD Million)
14. 6.14 CHEMICALS AND MATERIALS, BY DISEASE TYPE, 2024 (% SHARE)
15. 6.15 CHEMICALS AND MATERIALS, BY DISEASE TYPE, 2024 TO 2035 (USD Million)
16. 6.16 CHEMICALS AND MATERIALS, BY END-USER, 2024 (% SHARE)
17. 6.17 CHEMICALS AND MATERIALS, BY END-USER, 2024 TO 2035 (USD Million)
18. 6.18 CHEMICALS AND MATERIALS, BY PRODUCT TYPE, 2024 (% SHARE)
19. 6.19 CHEMICALS AND MATERIALS, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TEST TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY DISEASE TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY END-USER, 2025-2035 (USD Million)
  4. 7.2.4 BY PRODUCT TYPE, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Chemicals and Materials Market Segmentation

Chemicals and Materials By Test Type (USD Million, 2025-2035)

Serological Tests
Molecular Diagnostics
Imaging Tests
Biopsies

Chemicals and Materials By Disease Type (USD Million, 2025-2035)

Rheumatoid Arthritis
Lupus
Multiple Sclerosis
Type 1 Diabetes
Thyroid Disorders

Chemicals and Materials By End-user (USD Million, 2025-2035)

Hospitals
Diagnostic Laboratories
Research Institutes

Chemicals and Materials By Product Type (USD Million, 2025-2035)

Reagents
Instrumentations
Software

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”